Live tape
Top 8, mentions 7d6,728META2,070 mentions▲ +0.06GOOGL1,400 mentions▲ +0.02MUSE634 mentions▲ +0.07NVDA575 mentions▲ +0.08MSFT557 mentions▲ +0.06QQQ511 mentions▲ +0.08SPY494 mentions▲ +0.05TSLA487 mentions▲ +0.06

Equity · Technology

CHYM

Chime Financial, Inc. · NasdaqGS

$27 −0.22% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 25, 2026
Price · Chart
Our own end-of-day closes 62 sessions
$40 $20 30 Jun 25 Sep

The line runs $20.47 on 30 June through $27 on 25 September, on a scale from $20 to $40. Days the market did not trade hold the previous close, flat.

The chart above plots the price of CHYM over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 62 sessions over that window: $20.47 on 30 June 2026 through $27 on 25 September 2026.

Market cap $10.7B
P/E (TTM) 8.4
52-week range $16.43 – $35.57
Avg volume 526.3K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Sep 25, 2026

CHYM insider trades

SEC Form 4 · last 90 days · newest reported trade 16 Sep 2026
Open-market buys 0
Open-market sells 20
Net sold $88.84M
Non-trade filings 20
Date Insider Type Shares Value
16 Sep 2026 Feuille James Director Sell 256,837 $8.30M
15 Sep 2026 FRANKEL ADAM B General Counsel Sell 102,002 $3.40M
15 Sep 2026 Feuille James Director Sell 95,400 $3.17M
14 Sep 2026 Feuille James Director Sell 95,400 $3.25M
11 Sep 2026 CAROLAN SHAWN T Director Sell 277,007 $9.16M
11 Sep 2026 Feuille James Director Sell 258,398 $8.51M
11 Sep 2026 Marshall Cynthia Director Sell 20,000 $662K
10 Sep 2026 CAROLAN SHAWN T Director Sell 302,306 $10.04M
10 Sep 2026 Feuille James Director Sell 93,492 $3.10M
09 Sep 2026 King Ryan A Co-Founder Sell 42,421 $1.49M
08 Sep 2026 Asmerom Amine Chief Accounting Officer Sell 19,505 $643K
01 Sep 2026 Britt Christopher R Chief Executive Officer Sell 200,000 $6.41M

Showing the 12 most recent of 20 open-market trades in this window. The figures above count all of them.

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
15 Sep 2026 FRANKEL ADAM B General Counsel Option exercise 60,000 $994K
13 Sep 2026 Britt Christopher R Chief Executive Officer Option exercise 125,000
13 Sep 2026 King Ryan A Co-Founder Option exercise 75,000
09 Sep 2026 King Ryan A Co-Founder Other 34,941
01 Sep 2026 Britt Christopher R Chief Executive Officer Other 200,000
28 Aug 2026 Asmerom Amine Chief Accounting Officer Award 92,379
28 Aug 2026 FRANKEL ADAM B General Counsel Award 115,474
28 Aug 2026 Britt Christopher R Chief Executive Officer Other 88,618
18 Aug 2026 Britt Christopher R Chief Executive Officer Gift 11,382
18 Aug 2026 King Ryan A Co-Founder Gift 7,480
17 Aug 2026 Asmerom Amine Chief Accounting Officer Tax withheld 10,040 $321K
17 Aug 2026 Britt Christopher R Chief Executive Officer Tax withheld 12,160 $389K

Showing the 12 most recent of 20 compensation filings in this window. The figures above count all of them.

CHYM reported financials

SEC EDGAR XBRL

CHYM reported revenue of $2.2B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$1.0B.

Figure Reported Period
Revenue $2.2B 31 Dec 2025 fiscal year
Net income −$1.0B 31 Dec 2025 fiscal year
Diluted EPS −$4.27 31 Dec 2025 fiscal year
Total assets $2.0B 30 Jun 2026 at period end
Total equity $1.4B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

CHYM earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.07 $670M
31 Mar 2026 Q1 2026 $0.13 $647M
31 Dec 2025 FY 2025 $-4.27 $2.19B
30 Sep 2025 Q3 2025 $-0.15 $544M
30 Jun 2025 Q2 2025 $-7.29 $528M
31 Mar 2025 Q1 2026 $0.00 $519M
31 Dec 2024 FY 2025 $-0.39 $1.67B
30 Sep 2024 Q3 2025 $-0.34 $422M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CHYM institutional holders

SEC Form 13F

11 of the 45 institutional funds we track reported a CHYM position for the quarter ended 30 Jun 2026 — a combined $356.5M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Tiger Global Management Trimmed −52.3% shares 5,284,045 $108.2M
Dragoneer Investment Group Held (±25%) 4,308,999 $88.2M
Marshall Wace Held (±25%) −20.8% shares 2,687,572 $55.0M
Millennium Management Trimmed −31.9% shares 2,441,656 $50.0M
Renaissance Technologies Held (±25%) +12.8% shares 923,600 $18.9M
Citadel Advisors Trimmed −74.3% shares 750,530 $15.4M
Two Sigma Investments Added +52.2% shares 411,743 $8.4M
Tudor Investment Corp Trimmed −72.4% shares 207,682 $4.3M
D. E. Shaw & Co. Added +85.5% shares 199,387 $4.1M
Man Group Added +284.0% shares 154,225 $3.2M

Showing the 10 largest of 11 reported positions. The figures above count all of them.

Source: SEC EDGAR 13F filings

CHYM fails-to-deliver

SEC CNS data

On 31 Aug 2026, 40 shares of CHYM failed to deliver (about $1K).

Settlement date Shares failed Notional % of shares out
31 Aug 2026 40 $1K <0.001%
24 Aug 2026 3,934 $129K 0.001%
14 Aug 2026 788,921 $25.4M 0.199%

Source: SEC fails-to-deliver (CNS) data